FRANCISCO JAVIER
GRANDAS PÉREZ
Profesor titular de universidad
Universitat Autònoma de Barcelona
Barcelona, EspañaUniversitat Autònoma de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (11)
2021
-
Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community
Neurologia, Vol. 36, Núm. 2, pp. 101-111
-
Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia
Neurobiology of Aging, Vol. 99, pp. 99.e15-99.e22
-
Present and future of parkinson’s disease in Spain: Parkinson-2030 delphi project
Brain Sciences, Vol. 11, Núm. 8
2020
-
A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice
Brain Sciences, Vol. 10, Núm. 3
-
Erratum: A Spanish consensus on the use of safinamide for parkinson’s disease in clinical practice. (Brain sci. (2020) 10, 176)
Brain Sciences
-
Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease
Neurobiology of Aging, Vol. 87, pp. 139.e1-139.e7
2019
-
Impact of disease duration in effectiveness of treatment with levodopa-carbidopa intestinal gel and factors leading to discontinuation
Journal of Parkinson's Disease, Vol. 9, Núm. 1, pp. 173-182
-
Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism
Movement Disorders, Vol. 34, Núm. 10, pp. 1547-1561
-
Reply to: “Mitochondrial Parkinsonism due to SPG7/Paraplegin variants with secondary mtDNA depletion”
Movement Disorders
2013
-
EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease
European Journal of Neurology, Vol. 20, Núm. 1, pp. 16-34
2005
-
Optimization of use of levodopa in Parkinson's disease: Role of levodopa-carbidopa-entacapone combination
Neurologia, Vol. 20, Núm. 4, pp. 180-188